Oda van den Berg

Ms. Oda van den Berg

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2023 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
OBOda van den Berg
Oda van den Berg
KSKamelia R. Stanoeva
Kamelia R. Stanoeva
RZRens Zonneveld
Rens Zonneveld
DDDenise Hoek-Van Deursen
Denise Hoek-Van Deursen
FKFiona R. van der Klis
Fiona R. van der Klis
LKLaetitia M. Kortbeek
Laetitia M. Kortbeek
A third nationally representative serosurvey was performed to study the changes in Toxoplasma gondii (T. gondii) seroprevalence in the Netherlands over a 20-year time span and to identify and confirm risk factors for acquired toxoplasmosis. This cross-sectional study (conducted in 2016/2017) was designed similarly to the previous two studies (1995/1996 and 2006/2007) and included a questionnaire and serum sampling among Dutch residents. Factors associated with seropositivity for T. gondii were determined using multivariable analysis of the questionnaire-derived data. The earlier observed decrease in T. gondii seroprevalence between 1995/1996 and 2006/2007 (from 40.5% to 26.0%) did not continue into 2016/2017 (29.9%). Similarly to the previous studies, the seroprevalence increased with age and varied among regions. In all studies, higher T. gondii seropositivity was associated with increasing age, lower educational level, not living in the Southeast, and eating raw or semi-cooked pork. The incidence of congenital toxoplasmosis was estimated at 1.3/1000 (95% CI 0.9–1.8) live-born children in 2017. As the seroprevalence of T. gondii in the Netherlands did not decrease over the last decade, an increase in public health awareness is needed and prevention measures may need to be taken to achieve a further reduction in T. gondii infections in the Netherlands.

18 June 2026 in Eurosurveillance
Verified
Journal Article
Open access
OBOda van den Berg
Oda van den Berg
UTUkhsa Andv Team
Ukhsa Andv Team
ESEttore Severi
Ettore Severi
FMFreddy Mutoka-Banza
Freddy Mutoka-Banza
MVMichele van Vugt
Michele van Vugt
TTthe International ANDV team
the International ANDV team
As at 9 July 2026 †† , 13 cases (12 confirmed and one probable) of Andes orthohantavirus have been reported (case fatality: 23%), linked to the Dutch-flagged expedition cruise ship m/v Hondius . The event involved individuals from 23 nationalities and required medical evacuation, repatriation, coordinated international contact tracing, isolation, quarantine and clinical and laboratory testing follow-up. To date, all cases have been passengers (10/121; 8%) or crew members (3/61; 5%). Ongoing monitoring and investigations aim to clarify the source of the outbreak, identify risk factors and prevent further spread.

20 April 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
DHDieneke Hoeve-Bakker
Dieneke Hoeve-Bakker
OBOda van den Berg
Oda van den Berg
HDH. S. Doppenberg
H. S. Doppenberg
FKFiona R. M. van der Klis
Fiona R. M. van der Klis
CWCees C. van Den Wijngaard
Cees C. van Den Wijngaard
KKKaren Kerkhof
Karen Kerkhof
Lyme borreliosis (LB) is not notifiable in many European countries, and accurate data on the incidence are often lacking. This study aimed to determine the seroprevalence of Borrelia burgdorferi sensu lato (s.l.)-specific antibodies in the general population of The Netherlands, and to determine risk factors associated with seropositivity. Sera and questionnaires were obtained from participants (n = 5592, aged 0–88 years) enrolled in a nationwide serosurveillance study. The sera were tested for B. burgdorferi s.l.-specific IgM and IgG antibodies using ELISA and immunoblot. Seroprevalence was estimated controlling for the survey design. Risk factors for seropositivity were analyzed using a generalized linear mixed-effect model. In 2016/2017, the seroprevalence in The Netherlands was 4.4% (95% CI 3.5–5.2). Estimates were higher in men (5.7% [95% CI 4.4–7.2]) than in women (3.1% [95% CI 2.0–4.0]), and increased with age from 2.6% (95% CI 1.4–4.4) in children to 7.7% (95% CI 5.9–7.9) in 60- to 88-year-olds. The seroprevalence for B. burgdorferi s.l. in the general population in The Netherlands was comparable to rates reported in European countries. The main risk factors for seropositivity were increasing age, being male and the tick bite frequency. The dynamics of LB infection are complex and involve variables from various disciplines. This could be further elucidated using infectious disease modelling.

1 September 2021 in Ticks and Tick-borne Diseases
Verified
Journal Article
Open access
AHA. Hofhuis
A. Hofhuis
OBOda van den Berg
Oda van den Berg
FMF.S. Meerstadt-Rombach
F.S. Meerstadt-Rombach
CWC.C. van Den Wijngaard
C.C. van Den Wijngaard
NCN.H. Chung
N.H. Chung
JRJ.H.J. Reimerink
J.H.J. Reimerink
Tick-borne encephalitis virus (TBEV) has only recently been detected in the Netherlands. With still few autochthonous tick-borne encephalitis (TBE) patients, human exposure to TBEV is expected to be very low among the general population. We aimed to assess the exposure to TBEV among persons with an occupationally high risk of tick bites in the Netherlands. In our cross-sectional serological survey, employees and volunteers of nature management organizations provided a single blood sample and completed an online questionnaire in 2017. The sera were screened in the anti-TBEV IgG Enzyme-Linked Immunosorbent Assay (ELISA), after which a TBEV-specific virus neutralization test (VNT) was applied to confirm positive ELISA outcomes. Ten sera tested positive for IgG antibodies in the TBEV ELISA, among 556 participants who did not report vaccination against TBEV. Through confirmation in VNT, TBEV-specific IgG antibodies were detected among 0.5% (3/556, 95%CI 0.1%-1.6%). During the five years prior to the questionnaire, 87% reported tick bites. Half of the participants considered that most of their tick bites (75% to 100%) had been acquired while being at work. A very low seroprevalence of TBEV exposure was observed among these nature management workers, even though they report a six times higher exposure to tick bites, compared to our general population. Nonetheless, the emergence of TBEV in the Netherlands reaffirms the need for education and preventative measures against tick bites and tick-borne diseases.

31 July 2025 in Eurosurveillance
Verified
Journal Article
Open access
OBOda van den Berg
Oda van den Berg
DADana Ll Adriaansens
Dana Ll Adriaansens
MLMaren I Lanzl
Maren I Lanzl
KMKirsten Mooijman
Kirsten Mooijman
AHAngela van Hoek
Angela van Hoek
EFEelco Franz
Eelco Franz
Salmonella Enteritidis (SE) cases in humans have increased in the Netherlands, from an annual average of 281 (2017–2019) to 427 in 2023, 401 in 2024 and 209 in 2025 (January–June). This rise is paralleled by a 2.5-fold increase in SE-positive laying hen flocks. Genomic surveillance shows numerous small clusters, suggesting a diffuse transmission rather than a single point-source outbreak, which complicates outbreak investigations. Coordinated interventions in the laying hen sector are urgently needed to mitigate public health risks.

27 January 2021 in Southern African Journal of HIV Medicine
Verified
Journal Article
Open access
PDF file
OBOda van den Berg
Oda van den Berg
ESErica J. Shaddock
Erica J. Shaddock
SSSarah L. Stacey
Sarah L. Stacey
CFCharles Feldman
Charles Feldman
RBRoos E. Barth
Roos E. Barth
AVAlinda G. Vos
Alinda G. Vos
Background: With the roll-out of antiretroviral treatment (ART), the life expectancy of people with HIV and, hence, morbidity from non-communicable diseases, including pulmonary diseases, have increased. Objectives: This research study aims to investigate whether HIV infection and ART use are associated with pulmonary function, given the high frequency of pulmonary infections, including tuberculosis (TB), associated with HIV. Method: Adults living with HIV (ART-naïve, on first- or second-line ART), and age and sex matched HIV-negative controls were included in a cross-sectional study in Johannesburg, South Africa. Spirometry was performed to determine lung function, measuring the forced expiratory volume in one second (FEV1), the forced vital capacity (FVC) and the FEV1/FVC ratio before (pre), and after (post), short-acting bronchodilator. The association of HIV infection and ART use with pulmonary function was analysed using linear regression models, adjusting for age, gender, body surface area (BSA), employment, education, smoking and TB. Results: Overall, 548 participants (62% women) were included with a mean age of 38 (standard deviation [s.d.] 9.5) years. No effect of HIV or ART on post-FEV1 was observed in adjusted analysis. Additional adjustment for TB resulted in a higher post-FEV1 in participants on ART compared with HIV-negative participants, whereas TB was associated with a lower FEV1. No effect of HIV and ART on post-FEV1/FVC was observed. Conclusion: HIV infection and ART use were not associated with reduced pulmonary function in this urban African population. Tuberculosis showed a mediating effect on the association between HIV, ART and pulmonary function.